Your browser doesn't support javascript.
loading
A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in Tuberculosis.
Padmapriyadarsini, Chandrasekaran; Szumowski, John D; Akbar, Nabila; Shanmugasundaram, Prema; Jain, Anilkumar; Bathragiri, Marasamy; Pattnaik, Manoranjan; Turuk, Jyotirmayee; Karunaianantham, Ramesh; Balakrishnan, Senthilkumar; Pati, Sanghamitra; Kumar, A K Hemanth; Rathore, Manoj Kumar; Raja, Jegadeesh; Naidu, K Raghu; Horn, John; Whitworth, Laura; Sewell, Roger; Ramakrishnan, Lalita; Swaminathan, Soumya; Edelstein, Paul H.
Afiliación
  • Padmapriyadarsini C; National Institute for Research in Tuberculosis, Chennai, India.
  • Szumowski JD; Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, California, USA.
  • Akbar N; National Institute for Research in Tuberculosis, Chennai, India.
  • Shanmugasundaram P; National Institute for Research in Tuberculosis, Chennai, India.
  • Jain A; National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
  • Bathragiri M; Government Kilpauk Medical College and Hospital, Chennai, India.
  • Pattnaik M; Department of Pulmonary Medicine, SCB Medical College, Cuttack, India.
  • Turuk J; Regional Medical Research Centre, Bhubaneswar, India.
  • Karunaianantham R; National Institute for Research in Tuberculosis, Chennai, India.
  • Balakrishnan S; National Institute for Research in Tuberculosis, Chennai, India.
  • Pati S; Regional Medical Research Centre, Bhubaneswar, India.
  • Kumar AKH; National Institute for Research in Tuberculosis, Chennai, India.
  • Rathore MK; SITEC Labs, Navi Mumbai, India.
  • Raja J; SITEC Labs, Navi Mumbai, India.
  • Naidu KR; SITEC Labs, Navi Mumbai, India.
  • Horn J; Department of Pharmacy, University of Washington, Seattle, Washington, USA.
  • Whitworth L; Molecular Immunity Unit, Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Diseases, University of Cambridge, Cambridge, UK.
  • Sewell R; MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Ramakrishnan L; Trinity College, Cambridge, UK.
  • Swaminathan S; Molecular Immunity Unit, Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Diseases, University of Cambridge, Cambridge, UK.
  • Edelstein PH; MRC Laboratory of Molecular Biology, Cambridge, UK.
Clin Pharmacol Ther ; 115(2): 324-332, 2024 02.
Article en En | MEDLINE | ID: mdl-37983978
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tuberculosis / Mycobacterium tuberculosis Límite: Humans Idioma: En Revista: Clin Pharmacol Ther Año: 2024 Tipo del documento: Article País de afiliación: India
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tuberculosis / Mycobacterium tuberculosis Límite: Humans Idioma: En Revista: Clin Pharmacol Ther Año: 2024 Tipo del documento: Article País de afiliación: India